Akari Therapeutics Plc 4 filing

Filed 2026-07-17 · Report date 2026-07-07 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001493152-26-033634
Form type: 4
CIK: 0001541157
Primary document: https://www.sec.gov/Archives/edgar/data/1541157/000149315226033634/xslF345X06/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Akari Therapeutics Plc.

Reported financial metrics

Metric	Current	Prior	Change